Sicart Associates’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-10,460
| Closed | -$157K | – | 100 |
|
|
2017
Q3 | $157K | Sell |
10,460
-200
| -2% | -$3K | 0.11% | 73 |
|
|
2017
Q2 | $94K | Buy |
+10,660
| New | +$94K | 0.07% | 77 |
|
|
2017
Q1 | – | Sell |
-101,950
| Closed | -$311K | – | 103 |
|
|
2016
Q4 | $311K | Buy |
+101,950
| New | +$311K | 0.21% | 87 |
|